Postpartum depression: a developed and validated model predicting individual risk in new mothers.
Journal
Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664
Informations de publication
Date de publication:
30 09 2022
30 09 2022
Historique:
received:
14
06
2022
accepted:
15
09
2022
revised:
12
09
2022
entrez:
30
9
2022
pubmed:
1
10
2022
medline:
5
10
2022
Statut:
epublish
Résumé
Postpartum depression (PPD) is a serious condition associated with potentially tragic outcomes, and in an ideal world PPDs should be prevented. Risk prediction models have been developed in psychiatry estimating an individual's probability of developing a specific condition, and recently a few models have also emerged within the field of PPD research, although none are implemented in clinical care. For the present study we aimed to develop and validate a prediction model to assess individualized risk of PPD and provide a tentative template for individualized risk calculation offering opportunities for additional external validation of this tool. Danish population registers served as our data sources and PPD was defined as recorded contact to a psychiatric treatment facility (ICD-10 code DF32-33) or redeemed antidepressant prescriptions (ATC code N06A), resulting in a sample of 6,402 PPD cases (development sample) and 2,379 (validation sample). Candidate predictors covered background information including cohabitating status, age, education, and previous psychiatric episodes in index mother (Core model), additional variables related to pregnancy and childbirth (Extended model), and further health information about the mother and her family (Extended+ model). Results indicated our recalibrated Extended model with 14 variables achieved highest performance with satisfying calibration and discrimination. Previous psychiatric history, maternal age, low education, and hyperemesis gravidarum were the most important predictors. Moving forward, external validation of the model represents the next step, while considering who will benefit from preventive PPD interventions, as well as considering potential consequences from false positive and negative test results, defined through different threshold values.
Identifiants
pubmed: 36180471
doi: 10.1038/s41398-022-02190-8
pii: 10.1038/s41398-022-02190-8
pmc: PMC9525696
doi:
Substances chimiques
Antidepressive Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
419Subventions
Organisme : NIMH NIH HHS
ID : R01MH122869
Pays : United States
Organisme : Marie Curie
ID : 891079
Pays : United Kingdom
Informations de copyright
© 2022. The Author(s).
Références
Scand J Public Health. 2011 Jul;39(7 Suppl):95-8
pubmed: 21775363
Arch Womens Ment Health. 2014 Dec;17(6):519-28
pubmed: 25037970
Mol Psychiatry. 2022 Jun;27(6):2700-2708
pubmed: 35365801
Depress Anxiety. 2018 Feb;35(2):160-167
pubmed: 29172228
BMJ. 2015 Jan 07;350:g7594
pubmed: 25569120
BMJ. 2016 May 16;353:i2416
pubmed: 27184143
Schizophr Bull. 2021 Mar 16;47(2):284-297
pubmed: 32914178
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Lancet. 2014 Mar 15;383(9921):999-1008
pubmed: 24084292
Scand J Public Health. 2011 Jul;39(7 Suppl):22-5
pubmed: 21775345
JAMA Psychiatry. 2013 May;70(5):490-8
pubmed: 23487258
JAMA Psychiatry. 2018 Dec 1;75(12):1289-1297
pubmed: 30347013
JAMA Psychiatry. 2020 May 1;77(5):534-540
pubmed: 31774490
Stat Med. 2004 Aug 30;23(16):2567-86
pubmed: 15287085
N Engl J Med. 2016 Dec;375(22):2177-2186
pubmed: 27959754
Nat Rev Dis Primers. 2018 Apr 26;4:18022
pubmed: 29695824
JAMA. 2019 Feb 12;321(6):580-587
pubmed: 30747971
Heart. 2012 May;98(9):683-90
pubmed: 22397945
PLoS Med. 2008 Aug 5;5(8):e165; discussion e165
pubmed: 18684008
Eur J Epidemiol. 2018 Jan;33(1):27-36
pubmed: 29349587
Breast Cancer Res Treat. 2012 Apr;132(2):365-77
pubmed: 22037780
J Clin Med. 2020 Sep 08;9(9):
pubmed: 32911726
Depress Anxiety. 2021 Apr;38(4):400-411
pubmed: 33615617
Heart. 2012 May;98(9):691-8
pubmed: 22397946
J Affect Disord. 2006 Apr;91(2-3):97-111
pubmed: 16466664
BMJ. 2009 Mar 31;338:b604
pubmed: 19336487
Br J Psychiatry. 2019 Sep;215(3):519-527
pubmed: 30457060
Am J Psychiatry. 2016 Jun 1;173(6):635-42
pubmed: 26940804
Sci Rep. 2021 Apr 12;11(1):7877
pubmed: 33846362
J Clin Psychiatry. 2017 May;78(5):572-583
pubmed: 27337225
Biometrics. 2020 Jun;76(2):549-560
pubmed: 32134502
Psychol Med. 2020 Jul;50(9):1563-1569
pubmed: 31298172
J Affect Disord. 2021 Jan 15;279:1-8
pubmed: 33035748
JAMA. 2019 Feb 12;321(6):588-601
pubmed: 30747970
Psychol Med. 2017 Jun;47(8):1427-1441
pubmed: 28112056
JAMA. 2009 Dec 2;302(21):2345-52
pubmed: 19952321
J Obstet Gynecol Neonatal Nurs. 2002 Jul-Aug;31(4):394-402
pubmed: 12146928
J Clin Epidemiol. 2015 Mar;68(3):279-89
pubmed: 25179855
J Res Med Sci. 2012 Nov;17(11):1067-71
pubmed: 23833583
Transl Psychiatry. 2019 Nov 11;9(1):288
pubmed: 31712652
Scand J Public Health. 2011 Jul;39(7 Suppl):54-7
pubmed: 21775352
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
Lancet. 2014 Nov 15;384(9956):1775-88
pubmed: 25455248
Scand J Public Health. 2011 Jul;39(7 Suppl):38-41
pubmed: 21775349
J Psychiatr Res. 2015 Feb;61:205-13
pubmed: 25537450
Stat Med. 1997 May 15;16(9):965-80
pubmed: 9160492
Cancer Causes Control. 2018 Oct;29(10):967-986
pubmed: 30178398
J Clin Epidemiol. 2016 Nov;79:76-85
pubmed: 27262237
J Clin Psychiatry. 2017 May;78(5):e469-e476
pubmed: 28570797